Logo | Name | Σ | ||
---|---|---|---|---|
Caisse d’Epargne [Automatic translation follows] Cooperative banks, the Caisses d'Epargne have been combining trust, solidarity and modernity since 1818. The second largest banking network in France, the 16 regional Caisses d'Epargne are among the leading banks in their region. They support all economic players and are leaders in financing the public sector, social housing and the social economy. In total, the Caisses d'Epargne now have 4.8 million members and 20.6 million customers, managed by the 4,182 bank branches and the Mon banquier en ligne agency. | 2140 | 1546 | 747 | |
Pfizer We’re celebrating 175 years of daring scientific innovation—and we’re not done yet. Every day, we’re channeling our passion and resources into delivering innovative therapies that change the face of healthcare. Let’s outdo yesterday. Follow our progress as we accelerate the next generation of cancer treatments at LetsOutdoCancer.com For additional information on our guidelines, please visit http://www.pfizer.com/community-guidelines To apply science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe and effective and affordable medicines and health care services to the people who need them. Sectors: Pharmaceutical | 1356 | 1053 | 137 | |
AstraZeneca We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business Sectors: Pharmaceutical | 3770 | 2609 | 203 | |
Amgen #WeareBiotech Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen … Sectors: Biotechnology | 1611 | 935 | 333 | |
MEDICALPS [Automatic translation follows] The Alpine Arc Health Technology Cluster MEDICALPS is the Alpine Arc health technology cluster. Since 2000, the association has brought together and represented a network of more than 130 start-ups, SMEs, large groups, research centers, universities and communities from the fields of medical technologies, biotechnologies and e-health. The leadership of MEDICALPS, facilitator and unifier of this community, is largely entrusted to entrepreneurs, with the support of public stakeholders, with the aim of building the medicine of tomorrow. The association's operational programs serve the growth and visibility of the network of industrialists in the field of health technologies … | 188 | 70 | 141 | |
MSD At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse … Sectors: Pharmaceutical | 2104 | 1853 | 189 | |
Daiichi Sankyo Passion for Innovation. Compassion for Patients. Daiichi Sankyo is an innovative global healthcare company contributing to the sustainable development of society that discovers, develops, and delivers new standards of care to enrich the quality of life around the world. With more than 120 years of experience, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular, and other diseases with high unmet medical need. For all other inquiries about Daiichi Sankyo such as products or careers, please visit our website www.daiichisankyo.com. Please see below for global employment opportunities: Daiichi Sankyo … Sectors: Pharmaceutical | 17 | 12 | 1 |